| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3204 | M4k2009 Featured | M4K2209 is a potent, selective BMP type I receptor ALK2 inhibitor with IC50 of 9 nM, >180-fold selective over ALK5 (IC50=2427 nM). |
|
| DCC3205 | M4k2127 | Novel potent and selective ALK2 inhibitor, showing high initial brain uptake, including in the region of interest (pons) |
|
| DCC3206 | M4k2163 | Novel CNS Penetrant ALK2 Inhibitor for the Treatment of Diffuse Intrinsic Pontine Glioma |
|
| DCC3207 | M-5mpep | Partial antagonist of mGlu5 |
|
| DCC3208 | M7594_0037 | Novel Peptide Deformylase (PDF) Inhibitor, having inhibitory activity against HeLa, A549 and MCF-7 |
|
| DCC3209 | Mac-0547630 | Novel potent and selective inhibitor of UppS without off-target effects on membrane potential |
|
| DCC3210 | Mac13243 | Novel inhibitor of the bacterial lipoprotein targeting chaperone, LolA |
|
| DCC3211 | Macluraxanthone | Natural immunomodulator, significantly decreasing TNF-α and IL-10 cytokine production, regulating the NF-κB and MAPK signaling pathways, displaying the strongest antiproliferative effects with IC50 values of 2.84 and 0.95 μM against A431 and HeLa cancer c |
|
| DCC3212 | Madtp-372 | Potent and selective inhibitor of the induction of cytopathic effect by CHIKV and VEEV |
|
| DCC3213 | Madurmycin | Polyether ionophore antibiotic, inhibiting proliferation and induces apoptosis in myoblast cells |
|
| DCC3214 | Magl-2102 | Novel reversible monoacylglycerol lipase (MAGL) inhibitor |
|
| DCC3215 | Magnesium L-threonate | Inhibitor of TNF-α, preventing and restoring memory deficits associated with neuropathic pain |
|
| DCC3216 | Magnesium Oxaloacetate | Inhibitor of the amebicidal activity of activated murine macrophages, helping the parasite to survive within the mouse large intestine and increasing the survival of C. elegans exposed to H2O2 |
|
| DCC3217 | Magreth-16a | Potent CB2 receptor inverse agonist |
|
| DCC3218 | Malonganenone A | Selective modulator of plasmodial Hsp70s with antimalarial activity |
|
| DCC3219 | Malp-2 Featured | Toll-like receptor 2/6 (TLR-2/6) agonist, regulating Lcn2 gene, promoting collateral growth |
|
| DCC3220 | Malp-2s | TLR2/6 agonist, activating the MyD88 pathway, provoking natural killer (NK) cell activation, increasing co-stimulators CD80/86 and CD40 |
|
| DCC3221 | Mal-rp | Novel quantitative chemical probe for live cell labeling and imaging of proteins that are sensitive to redox modifications |
|
| DCC3222 | Manassantin A | Natural anticancer, anti-inflammatory, neuroleptic agent, also having human acyl-CoA:cholesterol acyltransferase (ACAT) inhibitory activities |
|
| DCC3223 | Mao-b Inhibitor 58 | Highly potent, selective, competitive, and reversible inhibitor of monoamine oxidase B (MAO-B). |
|
| DCC3224 | Mao-b Inhibitor C3 | Novel potent and highly selective MAO-B Inhibitor |
|
| DCC3225 | Mao-b Inhibitor C5 | Potent and selective MAO-B inhibitor |
|
| DCC3226 | Mao-b Inhibitor Cc1 | Novel potent selective and competitive inhibitor of MAO-B (IC 50 : 0.69 μM) |
|
| DCC3227 | Mao-b Inhibitor Cc2 | Novel potent and competitive inhibitor of MAO-B (IC 50 : 0.51 μM), also inhibiting BChE (IC 50 : 7.00 μM) |
|
| DCC3228 | Mao-b Ligand-1 | Novel selective MAO-B inhibitor |
|
| DCC3229 | Ma-pabc-adc-linker-18 | Novel stable antibody-drug conjugate (ADC) in mouse serum |
|
| DCC3230 | Maprotiline | Inhibitor of neuronal norepinephrine reuptake, reducing symptoms of anxiety associated with depression. |
|
| DCC3231 | Marbotinib | Novel highly efficient dual type I/II FMS-like tyrosine kinase inhibitor, disrupting the growth of leukemic cells |
|
| DCC3232 | Margatoxin | Inhibitor of voltage-gated K(+) (Kv) channels Kv1.3 and Kv1.5 |
|
| DCC3233 | Maritinone | Novel, active, and less toxic anti-tuberculosis (anti-TB) agent |
|
